These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29553045)

  • 1. Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?
    Çamtosun E; Şıklar Z; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):247-255. PubMed ID: 29553045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE; Attie KM; Baptista J;
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of one-year low-dose growth hormone (GH) therapy on body composition, lipid profile and carbohydrate metabolism in young adults with childhood-onset severe GH deficiency confirmed after completion of growth promotion.
    Hilczer M; Smyczyńska J; Stawerska R; Lewiński A
    Endokrynol Pol; 2008; 59(4):292-300. PubMed ID: 18777498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of discontinuation of growth hormone treatment on lipids and weight status in adolescents.
    Rothermel J; Lass N; Bosse C; Reinehr T
    J Pediatr Endocrinol Metab; 2017 Jul; 30(7):749-757. PubMed ID: 28672749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
    Baroncelli GI; Bertelloni S; Sodini F; Saggese G
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescents with partial growth hormone (GH) deficiency develop alterations of body composition after GH discontinuation and require follow-up.
    Tauber M; Jouret B; Cartault A; Lounis N; Gayrard M; Marcouyeux C; Pienkowski C; Oliver I; Moulin P; Otal P; Joffre F; Arnaud C; Rochiccioli P
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5101-6. PubMed ID: 14602733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase.
    Bazarra-Castro MÁ; Sievers C; Schwarz HP; Pozza SB; Stalla GK
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):507-10. PubMed ID: 23070828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency.
    Lee YJ; Choi Y; Yoo HW; Lee YA; Shin CH; Choi HS; Kim HS; Kim JH; Moon JE; Ko CW; Ahn MB; Suh BK; Choi JH
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):359-368. PubMed ID: 35504604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency.
    Kołtowska-Häggström M; Geffner ME; Jönsson P; Monson JP; Abs R; Hána V; Höybye C; Wollmann HA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2646-54. PubMed ID: 20335451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.